Eurobio Scientific S.A.
ALERS.PA · PAR
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | €258,775 | €183,356 | €208,170 | €292,021 |
| - Cash | €21,774 | €49,298 | €47,493 | €92,919 |
| + Debt | €34,055 | €100,660 | €113,603 | €15,677 |
| Enterprise Value | €271,056 | €234,718 | €274,280 | €214,779 |
| Revenue | €154,948 | €130,646 | €152,607 | €184,712 |
| % Growth | 18.6% | -14.4% | -17.4% | – |
| Gross Profit | €71,955 | €57,488 | €65,043 | €97,443 |
| % Margin | 46.4% | 44% | 42.6% | 52.8% |
| EBITDA | €20,400 | €24,545 | €40,492 | €79,632 |
| % Margin | 13.2% | 18.8% | 26.5% | 43.1% |
| Net Income | €4,000 | €4,835 | €24,937 | €60,544 |
| % Margin | 2.6% | 3.7% | 16.3% | 32.8% |
| EPS Diluted | 0.39 | 0.43 | 2.2 | 5.57 |
| % Growth | -9.3% | -80.5% | -60.5% | – |
| Operating Cash Flow | €16,703 | €26,767 | €41,848 | €65,461 |
| Capital Expenditures | -€3,256 | -€4,054 | -€2,834 | -€1,847 |
| Free Cash Flow | €13,447 | €22,713 | €39,014 | €63,614 |